Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma.

Dag HolmbergJoonas H KauppilaFredrik MattssonJohannes AsplundWilhelm LeijonmarckShao-Hua XieJesper Lagergren

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2022)

Low-dose aspirin use might not improve long-term survival after gastrectomy for gastric adenocarcinoma and may thus not be a target for adjuvant therapy in this group of patients.

Keyphrases

low dose
end stage renal disease
squamous cell carcinoma
high dose
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
antiplatelet therapy
locally advanced
type diabetes
patient reported outcomes
percutaneous coronary intervention